{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T08:32:44Z","timestamp":1793349164529,"version":"4.5.0"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Oncol"],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1001\/jamaoncol.2019.3718","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T11:45:39Z","timestamp":1572522339000},"page":"60","source":"Crossref","is-referenced-by-count":216,"title":["Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma"],"prefix":"10.1001","volume":"6","author":[{"given":"Andrea","family":"Cercek","sequence":"first","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Boerner","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Tan","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Medicine, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne F.","family":"Chou","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mithat","family":"G\u00f6nen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn M.","family":"Boucher","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley F.","family":"Hauser","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard K. G.","family":"Do","sequence":"additional","affiliation":[{"name":"Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maeve A.","family":"Lowery","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Harding","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Varghese","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Reidy-Lagunes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Saltz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Schultz","sequence":"additional","affiliation":[{"name":"Human Oncology & Pathogenesis, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Peter","family":"Kingham","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael I.","family":"D\u2019Angelica","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"DeMatteo","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, Department of Surgery, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Drebin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Allen","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Surgery, Duke University, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod P.","family":"Balachandran","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kian-Huat","family":"Lim","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Medicine, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Sanchez-Vega","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Surgery, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Vachharajani","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Surgery, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria B.","family":"Majella Doyle","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Surgery, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Fields","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Surgery, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Hawkins","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Surgery, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Strasberg","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Surgery, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Chapman","sequence":"additional","affiliation":[{"name":"School of Medicine, Department of Surgery, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Luis A.","family":"Diaz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Kemeny","sequence":"additional","affiliation":[{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Jarnagin","sequence":"additional","affiliation":[{"name":"Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"coi190075r1","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","article-title":"Changing international trends in mortality rates for liver, biliary and pancreatic tumours.","volume":"37","author":"Khan","year":"2002","journal-title":"J Hepatol"},{"issue":"5","key":"coi190075r2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the US: intrahepatic disease on the rise.","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"issue":"6","key":"coi190075r3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/gut.48.6.816","article-title":"Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.","volume":"48","author":"Taylor-Robinson","year":"2001","journal-title":"Gut"},{"issue":"6","key":"coi190075r4","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1158\/1055-9965.EPI-05-0811","article-title":"A comparison of trends in the incidence of hepatocellular carcinoma and intrahepatic cholangiocarcinoma in the United States.","volume":"15","author":"McGlynn","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"coi190075r5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/jnci\/djj234","article-title":"Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.","volume":"98","author":"Welzel","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"coi190075r6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1001\/jamasurg.2013.5137","article-title":"Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis.","volume":"149","author":"Mavros","year":"2014","journal-title":"JAMA Surg"},{"issue":"1","key":"coi190075r7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1245\/s10434-015-4642-9","article-title":"Management and Outcomes of Patients with Recurrent Intrahepatic Cholangiocarcinoma Following Previous Curative-Intent Surgical Resection.","volume":"23","author":"Spolverato","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"coi190075r8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2016.05.019","article-title":"Recurrence patterns and disease-free survival after resection of intrahepatic cholangiocarcinoma: preoperative and postoperative prognostic models.","volume":"223","author":"Doussot","year":"2016","journal-title":"J Am Coll Surg"},{"issue":"4","key":"coi190075r9","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S1072-7515(01)01016-X","article-title":"Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes.","volume":"193","author":"Weber","year":"2001","journal-title":"J Am Coll Surg"},{"issue":"1","key":"coi190075r10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/SLA.0b013e318176c4d3","article-title":"Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection.","volume":"248","author":"Endo","year":"2008","journal-title":"Ann Surg"},{"issue":"14","key":"coi190075r11","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.","volume":"362","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"coi190075r12","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/annonc\/mdh351","article-title":"Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study.","volume":"15","author":"Andr\u00e9","year":"2004","journal-title":"Ann Oncol"},{"issue":"17","key":"coi190075r13","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-18-0078","article-title":"Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: potential targets for intervention.","volume":"24","author":"Lowery","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"6","key":"coi190075r15","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1200\/JCO.1984.2.6.595","article-title":"Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma.","volume":"2","author":"Kemeny","year":"1984","journal-title":"J Clin Oncol"},{"issue":"1","key":"coi190075r16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.suronc.2007.04.008","article-title":"Epidemiology of colorectal liver metastases.","volume":"16","author":"McMillan","year":"2007","journal-title":"Surg Oncol"},{"issue":"2","key":"coi190075r17","first-page":"176","article-title":"Clinical pharmacology of hepatic arterial chemotherapy.","volume":"10","author":"Ensminger","year":"1983","journal-title":"Semin Oncol"},{"issue":"6","key":"coi190075r18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1634\/theoncologist.8-6-553","article-title":"An update on hepatic arterial infusion chemotherapy for colorectal cancer.","volume":"8","author":"Cohen","year":"2003","journal-title":"Oncologist"},{"issue":"9","key":"coi190075r19","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1093\/annonc\/mdp029","article-title":"Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.","volume":"20","author":"Jarnagin","year":"2009","journal-title":"Ann Oncol"},{"issue":"3-4","key":"coi190075r20","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000324704","article-title":"Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: does the addition of systemic bevacizumab improve results?","volume":"80","author":"Kemeny","year":"2011","journal-title":"Oncology"},{"issue":"3","key":"coi190075r21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology.","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"issue":"2","key":"coi190075r22","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"3","key":"coi190075r23","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.suronc.2017.05.003","article-title":"Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: a systematic review.","volume":"26","author":"Akinwande","year":"2017","journal-title":"Surg Oncol"},{"issue":"10","key":"coi190075r24","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1002\/cam4.2018.7.issue-10","article-title":"Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma.","volume":"7","author":"Elganainy","year":"2018","journal-title":"Cancer Med"},{"issue":"5","key":"coi190075r25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma.","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"coi190075r26","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1001\/jamaoncol.2019.0270","article-title":"Gemcitabine, cisplatin, and nab-paclitaxel for the treatment of advanced biliary tract cancers: a phase 2 clinical trial.","volume":"5","author":"Shroff","year":"2019","journal-title":"JAMA Oncol"},{"key":"coi190075r27","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djz071","article-title":"Advanced intrahepatic cholangiocarcinoma: post-hoc analysis of the ABC-01, -02 and -03 clinical trials.","author":"Lamarca","year":"2019","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"coi190075r28","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1002\/cncr.v123.8","article-title":"Local therapy reduces the risk of liver failure and improves survival in patients with intrahepatic cholangiocarcinoma: a comprehensive analysis of 362 consecutive patients.","volume":"123","author":"Yamashita","year":"2017","journal-title":"Cancer"},{"issue":"5","key":"coi190075r29","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/cncr.v122.5","article-title":"Unresectable intrahepatic cholangiocarcinoma: systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.","volume":"122","author":"Konstantinidis","year":"2016","journal-title":"Cancer"},{"issue":"15","key":"coi190075r30","article-title":"ClarIDHy: a phase 3, multicenter, randomized, double-blind study of AG-120 vs placebo in patients with an advanced cholangiocarcinoma with an IDH1 mutation","volume":"35","author":"Lowery","year":"2017","journal-title":"J Clin Oncol"},{"issue":"23","key":"coi190075r31","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1002\/cncr.v123.23","article-title":"Isocitrate dehydrogenase\u2013mutant glioma: evolving clinical and therapeutic implications.","volume":"123","author":"Miller","year":"2017","journal-title":"Cancer"},{"key":"coi190075r32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1182\/blood.V130.Suppl_1.725.725","article-title":"Ivosidenib (AG-120) in mutant IDH1 AML and advanced hematologic malignancies: results of a phase 1 dose escalation and expansion study.","volume":"130","author":"DiNardo","year":"2017","journal-title":"Blood"},{"key":"coi190075r14","unstructured":"ClinicalTrials.gov. Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy). NCT02989857. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02989857. Accessed October 1, 2019."}],"container-title":["JAMA Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/articlepdf\/2753558\/jamaoncology_cercek_2019_oi_190075.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:07:36Z","timestamp":1664755656000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2753558"}},"subtitle":["A Phase 2 Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoncol.2019.3718","relation":{},"ISSN":["2374-2437"],"issn-type":[{"value":"2374-2437","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}